Home › Funds › ATWOOD & PALMER INC › VRTX

ATWOOD & PALMER INC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

ATWOOD & PALMER INC reported holding 56,545 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$29.6M, representing 1.52% of its reported portfolio and ranking #31 among its reported holdings. ATWOOD & PALMER INC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)56.55K sh
Reported value held$29.56M
Portfolio Weight1.52%
First reportedQ3 2023
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How ATWOOD & PALMER INC's VRTX position evolved

ATWOOD & PALMER INC first disclosed a stake in VRTX in Q3 2023 at 52,320 shares (US$18.2M). The position peaked in Q3 2026 at 56,545 shares, worth US$29.6M. Across 13 filings, ATWOOD & PALMER INC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 56,545 shares valued at US$29.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 52.32K $18.19M New
Q4 2023 52.50K $21.36M Hold
Q1 2024 54.13K $22.63M Add
Q2 2024 54.27K $25.44M Hold
Q3 2024 54.26K $25.24M Hold
Q4 2024 55.39K $22.31M Add
Q1 2025 54.98K $26.66M Reduce
Q2 2025 55.19K $24.57M Hold
Q3 2025 55.30K $21.66M Hold
Q4 2025 55.39K $25.11M Hold
Q1 2026 55.75K $24.90M Add
Q2 2026 56.36K $27.99M Add
Q3 2026 56.55K $29.56M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has ATWOOD & PALMER INC held VRTX?

ATWOOD & PALMER INC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ATWOOD & PALMER INC's current position in VRTX?

As of Q3 2026, ATWOOD & PALMER INC holds 56.55K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $29.56M, representing 1.52% of its reported portfolio and ranking #31.

Has ATWOOD & PALMER INC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), ATWOOD & PALMER INC held unchanged its position in VRTX. The position peaked in Q3 2026 at 56.55K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.